Medica Sur SA de CV Class B
53.00
MXN
+0.50
(+0.95%)
ISIN
MXP510121215
Return %
Stock
S&P 500
1Y
6.00
13.14
3Y
31.25
80.78
5Y
23.54
67.74
Capital Structure
MXN
•
in mil. unless spec.Working Capital
MXN
•
in mil. unless spec.Growth Rates
MXN
•
in mil. unless spec.Quarterly Revenue
MXN
•
in mil. unless spec.Quarterly Earnings Per Share
MXN
•
in mil. unless spec.Quarterly Dividends Per Share
MXN
•
in mil. unless spec.Company Description
- CEO
- Octavio González Chon
- Full Time Employees
- 2,228
- Sector
- Health services
- Industry
- Medical/Nursing services
- Address
- Puente de Piedra 150 Mexico City DF Mexico 14050
- IPO Date
- Mar 10, 1994
- Website
- medicasur.com.mx
- Similar Companies
- Business
- Médica Sur, S.A.B. de C.V. (MEDICAB.MX) operates as a leading healthcare provider in Mexico, managing specialty hospitals, emergency and diagnostic centers, medical laboratories, organ and blood banks, and accommodation facilities. The company offers a comprehensive range of medical services including angiology, vascular and endovascular surgery; bariatric surgery; cancer treatment; cardiology; checkups and preventive medicine; pediatrics; dentistry; emergency care; endocrinology; gastroenterology, hepatology and endoscopy; general surgery; geriatrics; gynecology and obstetrics; specialized surgery; neonatology; neurology, neurosurgery and gamma knife radiosurgery; neurophysiology; nuclear medicine; orthopedics and traumatology; outpatient surgery; plastic surgery; robotic surgery; spine microsurgery; transplants; urology; vascular disease treatments; imaging and MRI services; anatomic pathology; oncology; ophthalmology; otolaryngology; radiology; and radiosurgery. Additional offerings encompass accommodation; concierge services; digital hospital and telemedicine; gourmet dining; assistance with insurance paperwork; medical tourism; tours and transportation; and pharmaceutical distribution. Founded in 1981 and headquartered in Mexico City at Puente de Piedra No. 150, Toriello Guerra, Tlalpan, the company serves patients through its flagship 190-bed facility featuring 15 operating rooms, 15 intensive care units, 13 adult emergency units, three pediatric emergency cubicles, one orthopedic emergency unit, and 542 medical offices across three towers. Specialized centers include the Integral Oncology Center with radiotherapy; Center for Neurology and Neurosurgery; Gastroenterology; Urology; Hemodynamics; Hemodialysis; Positron Emission Tomography; Comprehensive Diagnostic Center; and advanced imaging with tomography, magnetic resonance, and PET-CT. Médica Sur targets private patients, insured individuals, and international medical tourists, primarily in Mexico with a focus on high-complexity care, and operates through subsidiaries such as Corporacion de Atencion Medica SA de CV, El Portal Medico SA de CV, Servicios de Administracion Hospitalaria SA de CV, and Telemed SA de CV; it is a subsidiary of Neuco SAPI de CV and a member of the Mayo Clinic Care Network since 2014, marking its 10th anniversary in 2024 with enhanced collaboration including a Mayo Clinic patient information office opened in 2018. In recent developments, the company has maintained strategic stability with no major acquisitions or funding rounds reported in 2024-2025, instead focusing on operational enhancements such as ongoing equipment modernization including Pentero 900 microscopes, 4K laparoscopy towers, Lasik devices, cardiovascular systems, robotic clinical analyzers, OPMI Lumera 700 microscopes, and PET-CT upgrades. It continues to prioritize teaching, training for young doctors, and scientific publications while upholding JCI accreditation and top rankings as Mexico's leading hospital per America Economia. Geographic operations remain centered in Mexico City, serving national and international patients through its integrated healthcare model.